| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 May 2024 | 3 May 2024 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial year ended March 31 2024 and to consider recommending Final Dividend if any Outcome of Board Meeting (As Per BSE Announcement Dated on 10.05.2024) | ||
| Board Meeting | 17 Mar 2024 | 17 Mar 2024 |
| Based on recommendations of Nomination & Remuneration Committee, the Board of Directors in their meeting held today i.e., March 17, 2024, inter-alia, approved the re-designation of Mr. Shankha Banerjee by appointing him as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP) with effect from May 21, 2024 | ||
| Board Meeting | 1 Feb 2024 | 25 Jan 2024 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 inter alia to consider and approve the Un-audited (Standalone & Consolidated) Financial Results for the Quarter and Nine Months ended December 31 2023 and declaration of 2nd interim dividend if any on the equity shares of the Company for the Financial Year 2023-24. Board of Directors in their meeting held today i.e. February 01, 2024, inter-alia, considered and approved the following: i. Un-Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter & Nine Months ended December 31, 2023. ii. Payment of 2nd Interim Dividend of INR 12/- per equity share (@ 120% on a face value of INR 10/- per share) for the FY 2023-24. The record date for the purpose of payment of 2nd Interim Dividend shall be February 13, 2024. Financial Results for the quarter and nine months ended December 31, 2023 Outcome of Board Meeting held on February 01, 2024 Board of Directors in their meeting held on February 01, 2024 inter-alia approved payment of 2nd Interim Dividend for FY 2023-24 Board of Directors in their meeting held on February 01, 2024 approved payment of 2nd Interim Dividend for FY 2023-24 (As Per BSE Announcement Dated on 01.02.2024) | ||
| Board Meeting | 2 Nov 2023 | 25 Oct 2023 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 inter alia to consider and approve unaudited (standalone and consolidated) financial results for the Quarter and Half Year ended September 30 2023. Financial Results for the Quarter and Half Year ended September 30, 2023 Outcome of Board Meeting for approval of Financial Results for the Quarter and Half Year ended September 30, 2023 (As Per BSE Announcement dated on 02.11.2023) | ||
| Board Meeting | 27 Jul 2023 | 20 Jul 2023 |
| Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors is scheduled to be held on Thursday July 27 2023 to inter-alia consider and approve the Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30 2023 and to consider the proposal of declaration of interim dividend if any on the equity shares of the Company for the Financial Year 2023-24. Un-Audited Financial Results for the quarter ended June 30, 2023 Board of Directors in their meeting on July 27, 2023 approved payment of Interim Dividend INR 6/- per equity shares for FY 2023-24 Board Meeting Outcome of Board Meeting Held on July 27, 2023 Board of Directors in their meeting held on July 27, 2023, approved appointment of Mr. Gurinder Singh Kalra and Mr. Rajit Mehta as Independent Directors Board of Directors in their meeting held on July 27, 2023 approved granting of ESOPs to eligible employees (As per BSE Announcement Dated on 27/07/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
